Ovizio

Ovizio develops digital holographic interferometric microscopy products and builds 4D microscopic imaging devices and software based on digital holographic microscopy. ChemoMetec is a global leader in automated cell counting technology, providing high-quality instruments and responsive support to diverse industries worldwide. Following ChemoMetec’s acquisition of Ovizio in October 2024, Ovizio’s technology has been described as a proprietary cell counter based on holographic microscopy, used primarily in bioprocessing and in cell and gene therapy. Its online system is designed to connect to bioreactors through a disposable item, allowing cells to be continuously extracted for analysis and then returned to the bioreactor. ChemoMetec has also described the platform as supporting real-time, automated monitoring of critical quality attributes in bioprocesses, with label-free cell analysis and software designed for compliance-ready use. Core technology: digital holographic microscopy and holographic cell counting Main applications: bioprocessing, cell and gene therapy System features: online monitoring, continuous cell analysis, label-free measurement, disposable connection to bioreactors Software capability: quantitative data analysis and online acquisition for suspension cell cultures